Iranian
Biomedical Journal
Volume 22, Issue 6 (11-2018)
IBJ 2018, 22(6): 415-419 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Nakhaei S, Heidary H, Rahimian A, Vafadar M, Rohani F, Bahoosh G et al . A New Case of Chanarin-Dorfman Syndrome with a Novel Deletion in ABHD5 Gene. IBJ 2018; 22 (6) :415-419
URL: http://ibj.pasteur.ac.ir/article-1-2338-en.html
URL: http://ibj.pasteur.ac.ir/article-1-2338-en.html
Shahrbanoo Nakhaei 
, Hamed Heidary , Aliasghar Rahimian , Mahdi Vafadar , Farzaneh Rohani , G.R. Bahoosh , Davoud Amirkashani
, Hamed Heidary , Aliasghar Rahimian , Mahdi Vafadar , Farzaneh Rohani , G.R. Bahoosh , Davoud Amirkashani
Abstract:
Chanarin-Dorfman syndrome (CDS) is a rare autosomal recessive metabolic disorder caused by mutations in gene encoding the domain-5 of α/β-hydrolase enzyme (ABHD5). It is known as a natural lipid storage disorder arising from impaired lipid metabolism often characterized by hepatomegaly, myopathy, ataxia, non-bullous ichthyosiform erythroderma, hearing loss, and mental retardation. In the present study, we report two affected 28-month-old monozygotic twin boys as new cases of CDS. Genetic analysis was performed in patients, and the results showed a homozygote deletion in exon 4 of ABHD5. According to the the American College of Medical Genetics and Genomics, this variant is categorized as a pathogenic variant.
Type of Study: Case Report |
Subject:
Molecular Genetics & Genomics
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
IBJ is a member of Committee on Publication Ethics (COPE)
and follows its guidelines |
The articles of this journal are licensed under
a Creative Commons Attribution-NonDerivatives 4.0 International License. .png) |
 IBJ is owned and published by Pasteur Institute of Iran |